AmerisourceBergen CEO and leadership

Jim Cleary is Executive Vice President and Chief Financial Officer for AmerisourceBergen. Prior to being named to his current role in November 2018, Mr. Cleary served as Executive Vice President & Group President, Global Commercialization Services & Animal Health, where he focused on extending the work of AmerisourceBergen’s pharmaceutical commercialization solutions for manufacturers and animal health, and as Executive Vice President & President, AmerisourceBergen Animal Health. Mr. Cleary joined AmerisourceBergen in February 2015 following the Company’s acquisition of MWI Veterinary Supply, where he served as President from 2000 to 2002, and then Chief Executive Officer from 2002 to 2015, leading MWI through its initial public offering, many years of growth and its ultimate sale to AmerisourceBergen. Mr. Cleary joined MWI in 1997 as Director of National Accounts, and was later promoted to the role of Vice President, Demand Generation. Prior to that, he held management positions with Agri Beef Co., MWI's former parent, Morrison Knudsen Corporation and its affiliate MK Rail Corporation.Mr. Cleary graduated from Dartmouth College with a Bachelor of Arts in Economics and received his Masters of Business Administration from Harvard Business School.

Silvana Battaglia is an Executive Vice President and Chief Human Resources Officer at AMERISOURCEBERGEN CORP.

Leslie Donato is Executive Vice President and Chief Strategy Officer for AmerisourceBergen Corporation. In this role, she architects and leads the organization’s long-term growth strategy and oversees initiatives that aim to diversify the organization’s portfolio through innovative build or buy opportunities.

Ms. Donato has over 25 years of long-range strategy and healthcare industry expertise. Prior to being named to her current role, she was the Vice President of Strategy at Bayer Pharmaceuticals. Over the course of her career at Bayer, she led the US Business Unit for Hematology and Neurology and the global strategic marketing function for neurology.

Prior to these roles, Ms. Donato was a principal and founding partner of McKinsey & Company’s Philadelphia office. Over the course of her 14-year tenure with McKinsey & Company, she helped healthcare company executives improve performance across strategy, organization re-design and capability building, commercial excellence including brand strategy and sales force architecture and business development. While there, she also led the Mid-Atlantic office women’s initiative, responsible for attracting, developing and retaining talented female consultants. She started her career at Deloitte Consulting.

John G. Chou is Executive Vice President and Chief Legal Officer for AmerisourceBergen Corporation. In this role, he is responsible for legal, regulatory, corporate security, global business resilience and enterprise risk management. Previously, Mr. Chou served as Chief Legal & Business Officer from 2017 to 2019, with executive management responsibility of strategy, business development, innovation, legal and compliance functions. Prior to this, Mr. Chou was Executive Vice President and General Counsel of AmerisourceBergen Corporation.Before joining AmerisourceBergen in 2002, Mr. Chou was a partner with a large Philadelphia law firm. He has been practicing law for over 35 years and previously held senior legal positions both in-house and in private practice in the United States and the United Kingdom. Mr. Chou is a graduate of Harvard College and the University of Pennsylvania Law School. Actively involved in the community, his board affiliations and memberships include the Episcopal Community Services Board of Trustees and the Committee of Seventy Board of Directors.